Key facts
- Synbiotic Health’s last known valuation is $25.0M.
- It has raised $11.4M.
- Notable investors include Invest Nebraska.
- Synbiotic Health has filed 4 Form Ds with the SEC since 2020, most recently Mar 2022 ( sold).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Synbiotic Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Synbiotic Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synbiotic Health
Developer of probiotic products designed to serve the dietary supplements industry. The company offers human-native, clinically validated probiotic formulations supported by leading microbiome research, enabling supplement manufacturers to support consumer healthspan, vitality, and longevity.
- Sector
- Healthcare
- HQ
- Lincoln, NE, United States
- Founded
- 2020
- Employees
- 14
- Website
- synbiotichealth.com/
- Ownership
- Privately Held (backing)
Synbiotic Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synbiotic Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synbiotic Health in its N-PORT filings yet. We sweep new filings monthly.